(PharmaNewsWire.Com, December 16, 2017 ) The past few decades have witnessed significant success in the development of highly effective drug therapies for common cardiovascular disease. The widespread use of these therapies along with the rising cardiovascular disease accounts for the increasing market for cardiovascular therapeutics.
Cardiovascular therapeutic drugs refers to prescription medicines and drugs for diseases that are relating to the function and structure of the heart and blood vessels. Cardiovascular disease continues to be the major disease causing health problems and responsible for majority of the deaths worldwide. Major drug administered areas for cardiovascular problems includes heart failure, coronary artery diseases, blood clots, high cholesterol and others.
Cardiovascular disorders remains the most common cause of mortality and morbidity in the world and is an emerging threat. The primary drivers for the market includes increasing aging population, growth in the per capita medical spending and the epidemic of general medical problems such as diabetes and obesity. However, increasing cost of drug development and shrinking target population are restraining the growth of the market. Despite the extensive prevalence of the cardiovascular diseases, drug development pipelines has been stagnant for variety of reason.
Global cardiovascular therapeutic drugs market is segmented based on the type of disease and drug class. The market based on the disease is further segmented into Arteriosclerosis, Cardiac arrhythmias, Myocardial infarction, acute coronary syndrome, Peripheral artery disease, Coronary artery disease, hypertension, hyperlipidaemia, thrombosis, cardiac failure diseases and other cardiovascular diseases. Based on the drug class, the market is segmented into monotherapies and combination drug classes. Based on geography, market is segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa.
The major companies leading the cardiovascular therapeutic drugs industry includes AstraZeneca, Novartis, Bristol-Myers Squibb (BMS), Pfizer, Sanofi, Merck, Bayer, Takeda, boehringer ingelheim and Johnson & Johnson.
2) By Drug Class 2.1 Monotherapies 2.2 Combination Therapies
Scope of the Report
Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analysing the level of competition and business strategy development A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and sksillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
